Cystotech

Cystotech is a Danish MedTech company developing AI-based decision support for bladder cancer diagnostics. By integrating directly into existing cystoscopy equipment, Cystotech enables real-time detection of suspicious tissue during standard clinical procedures. The company addresses a critical challenge in bladder cancer care: diagnostic uncertainty in a disease characterised by high recurrence rates and lifelong patient follow-up.

Cystotech’s core technology, CystoAID®, is built on a large and proprietary clinical dataset consisting of still images, video and procedure data collected through close collaboration with clinicians. This dataset forms the foundation of the company’s AI models and represents a significant competitive advantage in a field where access to high-quality, real-world data is a major barrier. The solution is designed to support – not replace – clinicians by improving confidence in decision-making and reducing unnecessary interventions.

Bladder cancer patients often undergo repeated cystoscopies over many years, creating both clinical and psychological burden. By improving detection accuracy and consistency, CystoAID® has the potential to strengthen patient trust, support more targeted treatment decisions and contribute to more efficient use of healthcare resources.

Cystotech operates as a software-based MedTech company and is pursuing commercialization through partnerships with cystoscopy equipment manufacturers and distributors. The company has achieved CE marking and is preparing for market rollout in Europe, with longer-term ambitions for international expansion.

The team behind Cystotech combines deep clinical insight with strong software and regulatory expertise. Founded by clinicians who identified the problem firsthand, the company has demonstrated the ability to navigate complex clinical validation, regulatory requirements and product development — a critical capability in regulated healthcare markets.

Key facts

• Danish MedTech company

• AI-based decision support for bladder cancer diagnostics

• Proprietary clinical dataset forming the basis of CystoAID®

• CE-marked software integrated into existing cystoscopy workflows

• Focus on European commercialization with global potential

Team

• Claus Hansen, Co-CEO & Co-founder
• Anna Munk Hansen, Co-CEO & Co-founder
• Jacob Elmose Hansen, Chief Medical Officer & Co-founder
• Philip Butenko, Senior Software Engineer & Co-founder
• Thomas Grønning, It Security Specialist & Co-founder